🇺🇸 FDA
Pipeline program

Drug: B10 L-BPA Injection

CMUH114-REC1-042

Phase 2 small_molecule active

Quick answer

Drug: B10 L-BPA Injection for Head and Neck Cancer is a Phase 2 program (small_molecule) at Heron Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Heron Therapeutics
Indication
Head and Neck Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials